All In MedTech

Device Trial Radar · NCT02107222

The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD)

A Multicenter Randomized Control Trial (RCT) to Determine Safety and Efficacy of PALP™ for ECCO2-R in Conjunction With Liberation From Mechanical Ventilation (MV) Compared to MV Alone in COPD Exacerbation and Respiratory Failure

Last checked: Nov 21, 2026Latest source record: Apr 1, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Not stated

Primary completion

Dec 2016

Sponsor

Lead sponsor
Maquet Cardiopulmonary GmbHNot on our public-company list
Sponsor type
Industry
First posted
Apr 8, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Multicenter, Randomized, Controlled Trial to Determine Safety and Efficacy of Pump Assisted Lung Protection (PALP™) for Low Flow Carbon Dioxide (CO2) Removal in Conjunction with Liberation from Mechanical Ventilation Compared to Mechanical Ventilation Alone in Patients with COPD Exacerbation and Respiratory Failure

Conditions

  • COPD
  • Chronic Obstructive Pulmonary Disease

Interventions

  • CO2-Removal (PALP-Device/MaquetCP)Device

    extracorporeal circuit to remove CO2 out of the blood

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Difference in time of mechanical ventilationTime frame: 720 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • MAQUET Cardiopulmonary AG

    Rastatt, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.